13 Best Forever Stocks to Invest In Now
On October 11, Tom Lee from Fundstrat appeared on CNBC Television to discuss the recent market decline, as the S&P 500 dropped by around 2.9% on Friday, October 10.
Merck & Co. Inc. (MRK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 37,439 | $3,142,292 | -6% | 1.47% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.25 | 2,833 | $249,999.98 | 2,933 | 2025-02-06 | Filing | |
| $88.50 | 15,000 | $1,327,500.00 | 16,000 | 2025-02-05 | Filing | |
| $113.68 | 3 | $341.04 | 20,599 | 2023-04-26 | Filing | |
| $105.47 | 136 | $14,343.92 | 20,631 | 2023-03-20 | Filing | |
| $109.20 | 11 | $1,201.20 | 20,495 | 2023-02-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.76 | 4,262 | $352,723.12 | 7,778 | 2025-04-25 | Filing | |
| $84.09 | 8,500 | $714,744.60 | 30,705 | 2025-02-19 | Filing | |
| $85.34 | 6,000 | $512,056.80 | 24,123 | 2025-02-13 | Filing | |
| $88.76 | 2,361 | $209,550.79 | 7,085 | 2025-02-06 | Filing | |
| $125.50 | 38,291 | $4,805,520.50 | 50,908 | 2024-02-14 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,496,664 | $461,335,010 | 0.63% | |
| 2. | 947,869 | $74,483,544 | 0.73% | |
| 3. | 685,693 | $57,550,249 | 0.06% | |
| 4. | 634,385 | $53,243,933 | 0.37% | |
| 5. | 644,798 | $50,655,331 | 3.34% |
News See All
Merck Completes $10B Acquisition of Verona Pharma, Adds COPD Drug Ohtuvayre
Merck & Co. Inc. (NYSE:MRK) is one of the best growth stocks to buy now. On October 7, Merck & Co. announced the completion of its acquisition of Verona Pharma (NASDAQ:VRNA).
Merck Initiates Three New Phase 2b Trials for Investigational Inflammatory Drug Tulisokibart
Merck & Co. Inc. (NYSE:MRK) is one of the most promising stocks under $100. On October 6, Merck & Co. announced the initiation of three new Phase 2b trials for tulisokibart (MK-7240).
12 Best Growth Stocks to Buy Now
On October 1, Keith Lerner, Chief Investment Officer at Truist Wealth, appeared on CNBC and stated that the shutdown fears are muted, and investors are not overly concerned right now.
14 Most Promising Stocks Under $100
On October 10, Tom Lee of Fundstrat joined 'Closing Bell' on CNBC to suggest that the S&P can still get to at least 7,000 this year. Tom Lee stated that markets are attempting to balance a few things.
Chart Expert Says Merck (MRK) Has More Upside - Here’s Why
Carter Worth from Worth Charting said in a latest program on CNBC that Merck & Co Inc (NYSE:MRK) is one of the stocks that has more upside potential based on his analysis.
Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks
An American multinational pharmaceutical company, Merck & Co., Inc. (NYSE:MRK) is one of the most profitable stocks that pay dividends, with a trailing twelve-month net profit margin of 25.8%.
13 Most Profitable Dividend Stocks to Buy Right Now
In a period marked by market volatility, ongoing policy and geopolitical uncertainty, many investors have been shifting toward fixed-income assets and away...
Top 10 Trending Stocks as Famous Billionaire Predicts Massive AI Stock Rally Before Bubble Burst
Experts are sounding the alarm bell about a potential AI bubble burst sooner or later. But many believe major AI stocks still have a lot of room to run before seeing a correction.
11 Best and Cheap Stocks to Buy Right Now
On October 3, Wharton professor and WisdomTree Chief Economist Jeremy Siegel joined CNBC for an interview to discuss the current and near-future outlook for the stock market.
Hedge Fund Resource Center Billionaire Hedge Funds
